Research Note: Snapshot of the transcriptome via RNA sequencing in the ileum of broiler chickens fed subtherapeutic concentrations of avilamycin.
avilamycin
gene set enrichment analysis
ileum
poultry
transcriptomics
Journal
Poultry science
ISSN: 1525-3171
Titre abrégé: Poult Sci
Pays: England
ID NLM: 0401150
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
13
07
2020
revised:
05
11
2020
accepted:
09
11
2020
entrez:
1
2
2021
pubmed:
2
2
2021
medline:
8
5
2021
Statut:
ppublish
Résumé
Antibiotics have played a critical role in sustaining and improving livestock production in the past decades, but the emergence of antimicrobial resistance has led several countries to ban or limit their use. Since then, in-feed alternatives have gained a lot of attention but the development of efficacious alternatives implies a better understanding of the mode of action of antibiotic growth promoters (AGP) when administered at subtherapeutic concentrations. In the present study, 120 broiler chickens per group (8 pens/group) were fed for 35 d with either basal feed (control group) or feed supplemented with avilamycin (AGP group; 10 g/1,000 kg of feed). At the end of the trial, the ileum from the small intestine of 5 birds per group was sampled, and RNA were isolated for profiling their transcriptome via RNA sequencing (RNA-Seq). As expected, the growth of chickens in the AGP group was significantly higher than in the control group. Overall, 66 differentially expressed genes (false discovery rate ≤ 0.05 and fold change ≥ 2 or ≤ -2) were found in the ileum of chickens fed avilamycin in comparison with the control group. The functional analysis showed reduced activity of genes related to signaling by interleukins, with IL-22, SOCS3, and certain antimicrobial peptides found multiple times in these pathways in the AGP group at day 35. In addition, higher activity was predicted in a module of genes related to lipid metabolism and transport in the avilamycin group. The use of RNA-Seq allowed a snapshot of the whole transcriptome at day 35 and aimed at delivering additional data on the host-centric hypothesis regarding the mode of action of AGP (i.e. immunomodulation, reduction of the immunological stress).
Identifiants
pubmed: 33518154
pii: S0032-5791(20)30858-0
doi: 10.1016/j.psj.2020.11.012
pmc: PMC7858091
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Oligosaccharides
0
avilamycin
720WDX56D3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
998-1003Informations de copyright
Copyright © 2020. Published by Elsevier Inc.
Références
Poult Sci. 2007 Nov;86(11):2466-71
pubmed: 17954599
Mucosal Immunol. 2008 Sep;1(5):335-8
pubmed: 19079197
Appl Microbiol Biotechnol. 2017 Jun;101(11):4547-4559
pubmed: 28243710
Poult Sci. 2007 Apr;86(4):605-9
pubmed: 17369528
Cytokine. 2012 Dec;60(3):815-27
pubmed: 22980486
Gut Pathog. 2011 Sep 25;3(1):14
pubmed: 21943280
Int J Antimicrob Agents. 2017 Jan;49(1):12-24
pubmed: 27717740
Poult Sci. 2018 Mar 1;97(3):970-979
pubmed: 29253227
J Nutr. 2004 Jun;134(6):1487-92
pubmed: 15173416